Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
However, the top specialists at Blue Fin Vision employ various approaches that may benefit certain patients: Acute Management: Immediate discontinuation of GLP-1 medication when NAION is confirmed Corticosteroid therapy in selected cases Comprehensive cardiovascular risk factor assessment Secondary Prevention: Aggressive management of vascular risk factors Blood pressure optimisation Aspirin therapy consideration Regular monitoring of the unaffected eye Risk Factors and Patient Selection Certain patient populations require particularly careful consideration before initiating GLP-1 therapy: High-Risk Patients: Individuals with pre-existing diabetic retinopathy Patients with poorly controlled diabetes and high HbA1c levels Those with cardiovascular risk factors Elderly patients Individuals with optic nerve head abnormalities The experienced team at Blue Fin Vision collaborates closely with endocrinologists and primary care physicians to ensure appropriate patient selection and monitoring protocols
The side effects of GLP-1 RAs can include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which are usually transient but may affect patient adherence, as well as rarer complications that require careful monitoring in clinical practice
Doctors have long observed a phenomenon sometimes described as the thin-fat Indian pattern
Diabetologia, 60, 15771585
Together, we help you benefit from your medications while keeping your eyes as healthy as possible
